JP2024067008A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024067008A5 JP2024067008A5 JP2023186694A JP2023186694A JP2024067008A5 JP 2024067008 A5 JP2024067008 A5 JP 2024067008A5 JP 2023186694 A JP2023186694 A JP 2023186694A JP 2023186694 A JP2023186694 A JP 2023186694A JP 2024067008 A5 JP2024067008 A5 JP 2024067008A5
- Authority
- JP
- Japan
- Prior art keywords
- peak
- theta
- cancer
- ray powder
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263421636P | 2022-11-02 | 2022-11-02 | |
| US63/421,636 | 2022-11-02 | ||
| US202263423879P | 2022-11-09 | 2022-11-09 | |
| US63/423,879 | 2022-11-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024067008A JP2024067008A (ja) | 2024-05-16 |
| JP2024067008A5 true JP2024067008A5 (enExample) | 2024-10-24 |
| JP7712994B2 JP7712994B2 (ja) | 2025-07-24 |
Family
ID=88978500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023186694A Active JP7712994B2 (ja) | 2022-11-02 | 2023-10-31 | 疾患の治療用のホスホイノシチド３－キナーゼ（ｐｉ３ｋ）のアロステリッククロメノン阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4612136A1 (enExample) |
| JP (1) | JP7712994B2 (enExample) |
| KR (1) | KR20250097960A (enExample) |
| CN (1) | CN120476112A (enExample) |
| AU (1) | AU2023373670A1 (enExample) |
| MX (1) | MX2025005020A (enExample) |
| TW (1) | TWI887826B (enExample) |
| WO (1) | WO2024097205A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119874676A (zh) * | 2023-10-25 | 2025-04-25 | 海创药业股份有限公司 | 一种pi3k抑制剂及其制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89840A (en) * | 1988-04-06 | 1996-10-31 | Lipha | Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them |
| JP4646626B2 (ja) | 2002-08-16 | 2011-03-09 | アストラゼネカ アクチボラグ | ホスホイノシチド３−キナーゼβの阻害 |
| PL2350082T3 (pl) | 2008-10-31 | 2015-08-31 | C A I R Biosciences Gmbh | Sól likofelonu z choliną i trometaminą |
| EP3369730B1 (en) | 2012-11-05 | 2020-08-05 | Emory University | 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto |
| US10519165B2 (en) | 2017-03-03 | 2019-12-31 | Gilead Sciences, Inc. | Processes for preparing ACC inhibitors and solid forms thereof |
| AR121719A1 (es) * | 2020-04-03 | 2022-06-29 | Petra Pharma Corp | Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades |
| WO2022235574A1 (en) | 2021-05-03 | 2022-11-10 | Petra Pharma Corporation | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease |
-
2023
- 2023-10-31 WO PCT/US2023/036445 patent/WO2024097205A1/en not_active Ceased
- 2023-10-31 JP JP2023186694A patent/JP7712994B2/ja active Active
- 2023-10-31 TW TW112141733A patent/TWI887826B/zh active
- 2023-10-31 KR KR1020257018231A patent/KR20250097960A/ko active Pending
- 2023-10-31 EP EP23814294.7A patent/EP4612136A1/en active Pending
- 2023-10-31 AU AU2023373670A patent/AU2023373670A1/en active Pending
- 2023-10-31 CN CN202380089690.XA patent/CN120476112A/zh active Pending
-
2025
- 2025-04-30 MX MX2025005020A patent/MX2025005020A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022186995A5 (enExample) | ||
| AU2016240841C1 (en) | Crystal of 3,5-disubstituted benzene alkynyl compound | |
| JP2024067008A5 (enExample) | ||
| JP2021119136A5 (enExample) | ||
| EA030435B1 (ru) | ТАБЛЕТКА, СОДЕРЖАЩАЯ МОДУЛЯТОР c-MET В ФОРМЕ КРИСТАЛЛИЧЕСКОЙ L-МАЛАТНОЙ СОЛИ (ВАРИАНТЫ), СПОСОБ ЕЕ ПРОИЗВОДСТВА И СПОСОБ ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКОГО ЗАБОЛЕВАНИЯ С ЕЕ ИСПОЛЬЗОВАНИЕМ | |
| Capsoni et al. | Improving the carprofen solubility: synthesis of the Zn2Al-LDH hybrid compound | |
| JP2020517611A5 (enExample) | ||
| US20250281492A1 (en) | New crystalline forms of salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide | |
| CA2514977A1 (en) | Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) | |
| CN108658966A (zh) | 选择性cdk9抑制剂的酒石酸盐及其晶型 | |
| JPWO2018139626A1 (ja) | キナゾリン誘導体を含有する固形製剤 | |
| JP2020138960A5 (enExample) | ||
| TW201345913A (zh) | 結晶形式 | |
| CN110520425B (zh) | EOC315 Mod.I晶型化合物及其制备方法 | |
| RU2016114904A (ru) | Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения | |
| JP2019518062A (ja) | Ｎ−（２−（２−（ジメチルアミノ）エトキシ）−４−メトキシ−５−（（４−（１−メチル−１ｈ−インドール−３−イル）ピリミジン−２−イル）アミノ）フェニル）アクリルアミドの薬学的塩およびそれらの結晶形 | |
| JP7571354B2 (ja) | キナーゼ阻害剤の多形体、このような化合物を含有する医薬組成物、調製方法、および適用 | |
| JP2024037713A5 (enExample) | ||
| CN112119073A (zh) | 阿贝西尼的固态形式、其用途和制备 | |
| MX2009007785A (es) | COMPLEJOS DE INCLUSION DE CLORHIDRATO DE RALOXIFENO Y ß-CICLODEXTRINA. | |
| JPWO2022137106A5 (enExample) | ||
| AU2012347393A1 (en) | Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide | |
| CN107922322B (zh) | 化合物n-(3,5-二甲基苯基)-n′-(2-三氟甲基苯基)胍的制备方法 | |
| HK1246297B (zh) | 3，5-二取代的苯炔基化合物晶体 | |
| HK40010533A (en) | Compound of eoc315 mod.i crystal form and preparation method thereof |